Published in Eur J Pediatr on September 02, 2010
Use of off-label and unlicenced drugs in hospitalised paediatric patients: a systematic review. Eur J Clin Pharmacol (2014) 1.03
In Italy anti-asthmatic drug prescription is not always a reliable proxy of asthma. Eur J Epidemiol (2016) 0.95
Drug use profile in outpatient children and adolescents in different Italian regions. BMC Pediatr (2013) 0.86
An inventory of European data sources for the long-term safety evaluation of methylphenidate. Eur Child Adolesc Psychiatry (2013) 0.85
Asthma prevalence and risk factors among children and adolescents living around an industrial area: a cross-sectional study. BMC Public Health (2013) 0.80
Utilisation and off-label prescriptions of respiratory drugs in children. PLoS One (2014) 0.80
Antibiotic-Induced Liver Injury in Paediatric Outpatients: A Case-Control Study in Primary Care Databases. Drug Saf (2016) 0.79
Initial step-up treatment changes in asthmatic children already prescribed inhaled corticosteroids: a historical cohort study. NPJ Prim Care Respir Med (2015) 0.77
Time trends of period prevalence rates of patients with inhaled long-acting beta-2-agonists-containing prescriptions: a European comparative database study. PLoS One (2015) 0.75
Ketotifen-induced nocturnal bruxism. Eur J Pediatr (2013) 0.75
Antibiotic and anti-asthmatic drug prescriptions in Italy: geographic patterns and socio-economic determinants at the district level. Eur J Clin Pharmacol (2013) 0.75
Oral prednisolone for preschool children with acute virus-induced wheezing. N Engl J Med (2009) 7.24
The introduction of computer-based patient records in The Netherlands. Ann Intern Med (1993) 6.38
Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J (2008) 3.36
Postmarketing surveillance based on electronic patient records: the IPCI project. Methods Inf Med (1999) 2.63
Prevalence of asthma-like symptoms in young children. Pediatr Pulmonol (2007) 2.17
Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy (2008) 1.97
Meta-analysis: respiratory tolerance to regular beta2-agonist use in patients with asthma. Ann Intern Med (2004) 1.95
Drug use in children: cohort study in three European countries. BMJ (2008) 1.91
Beyond randomized controlled trials: a critical comparison of trials with nonrandomized studies. Hepatology (2006) 1.87
Drug utilisation profile in the Italian paediatric population. Eur J Pediatr (2008) 1.67
The gap between evidence-based medicine and daily practice in the management of paediatric asthma. A pharmacy-based population study from The Netherlands. Eur J Clin Pharmacol (2005) 1.53
The potential of UK clinical databases in enhancing paediatric medication research. Br J Clin Pharmacol (2005) 1.29
Has asthma medication use in children become more frequent, more appropriate, or both? Pediatrics (1999) 1.28
Active monitoring of adverse drug reactions in children. Italian Paediatric Pharmacosurveillance Multicenter Group. Lancet (2000) 1.25
Prescription of respiratory medication without an asthma diagnosis in children: a population based study. BMC Health Serv Res (2008) 1.16
Use of anti-asthmatic medications as a proxy for prevalence of asthma in children and adolescents in Norway: a nationwide prescription database analysis. Eur J Clin Pharmacol (2007) 1.15
The effect of inhaled fluticasone propionate in the treatment of young asthmatic children: a dose comparison study. Am J Respir Crit Care Med (1999) 1.10
Inappropriate use of anti-asthmatic drugs in the Italian paediatric population. Eur J Clin Pharmacol (2003) 1.10
Defining off-label and unlicensed use of medicines for children: results of a Delphi survey. Pharmacol Res (2008) 1.08
Databases for pediatric medicine research in Europe--assessment and critical appraisal. Pharmacoepidemiol Drug Saf (2008) 1.07
Respiratory medications and risk of asthma death. Thorax (2002) 1.06
Long-acting beta2 agonists and paediatric asthma. Lancet (2006) 1.06
Glucocorticoid therapy for asthma: clinical pharmacology. J Allergy Clin Immunol (1991) 1.01
Anti-asthmatic drug prescriptions to an Italian paedriatic population. Pediatr Allergy Immunol (2008) 1.00
The beta-agonist controversy. Med Clin North Am (1996) 1.00
Local oropharyngeal side effects of inhaled corticosteroids in patients with asthma. Allergy (2006) 0.98
Does your child have asthma? Filled prescriptions and household report of child asthma. J Pediatr Health Care (2006) 0.94
Anti-inflammatory pharmacotherapy for wheezing in preschool children. Pediatr Pulmonol (2007) 0.93
Asthma medication use in school-aged children. J Asthma (2006) 0.84
Transition to managed care impacts health care service utilization by children insured by Medicaid. J Asthma (2007) 0.80
Efficacy and safety of inhaled corticosteroids in combination with a long-acting beta2-agonist in asthmatic children under age 5. J Asthma (2004) 0.80
Asthma-related medication use among children in the United States. Ann Allergy Asthma Immunol (2008) 0.79
Users of antiasthma drugs in Iceland: a drug utilization study. Eur Respir J (1997) 0.77
Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA (2004) 6.06
Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol (2006) 5.39
Daily telemonitoring of exhaled nitric oxide and symptoms in the treatment of childhood asthma. Am J Respir Crit Care Med (2008) 3.87
Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. Eur Heart J (2004) 3.52
Corticosteroids and the risk of atrial fibrillation. Arch Intern Med (2006) 3.28
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial. Lancet Infect Dis (2011) 3.04
Electronic alerts versus on-demand decision support to improve dyslipidemia treatment: a cluster randomized controlled trial. Circulation (2008) 2.81
Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death. Eur Heart J (2005) 2.72
Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project. Pharmacoepidemiol Drug Saf (2010) 2.57
Metabolomics applied to exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med (2007) 2.42
Unlicensed and off label prescription of drugs to children: population based cohort study. BMJ (2002) 2.34
Incidence rates and treatment of neuropathic pain conditions in the general population. Pain (2008) 2.30
Aldehydes and glutathione in exhaled breath condensate of children with asthma exacerbation. Am J Respir Crit Care Med (2002) 2.28
Use of tiotropium Respimat Soft Mist Inhaler versus HandiHaler and mortality in patients with COPD. Eur Respir J (2013) 2.27
High-risk use of over-the-counter non-steroidal anti-inflammatory drugs: a population-based cross-sectional study. Br J Gen Pract (2014) 2.27
Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection. AIDS (2006) 2.26
PENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV-1 infection. HIV Med (2009) 2.16
Age and CD4 count at initiation of antiretroviral therapy in HIV-infected children: effects on long-term T-cell reconstitution. J Infect Dis (2011) 2.13
Association between calcium channel blockers and gingival hyperplasia. J Clin Periodontol (2010) 2.07
Increased risk of achilles tendon rupture with quinolone antibacterial use, especially in elderly patients taking oral corticosteroids. Arch Intern Med (2003) 2.02
Re-using Mini-Sentinel data following rapid assessments of potential safety signals via modular analytic programs. Pharmacoepidemiol Drug Saf (2013) 2.01
Adverse drug reaction-related hospitalisations: a nationwide study in The Netherlands. Drug Saf (2006) 2.01
Multicenter prospective study of the burden of rotavirus acute gastroenteritis in Europe, 2004-2005: the REVEAL study. J Infect Dis (2007) 1.99
Drug use in children: cohort study in three European countries. BMJ (2008) 1.91
Association of community-acquired pneumonia with antipsychotic drug use in elderly patients: a nested case-control study. Ann Intern Med (2010) 1.91
A cross-national study of subjective sexual well-being among older women and men: findings from the Global Study of Sexual Attitudes and Behaviors. Arch Sex Behav (2006) 1.87
Genome-wide association study of intracranial aneurysm identifies three new risk loci. Nat Genet (2010) 1.86
Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults. Br J Psychiatry (2009) 1.84
Using electronic health care records for drug safety signal detection: a comparative evaluation of statistical methods. Med Care (2012) 1.82
Systems medicine and integrated care to combat chronic noncommunicable diseases. Genome Med (2011) 1.78
Antipsychotics and the risk of sudden cardiac death. Arch Intern Med (2004) 1.78
Asymmetric dimethylarginine in exhaled breath condensate and serum of children with asthma. Chest (2013) 1.77
Mefloquine increases the risk of serious psychiatric events during travel abroad: a nationwide case-control study in the Netherlands. J Clin Psychiatry (2005) 1.72
Childhood asthma and environmental exposures at swimming pools: state of the science and research recommendations. Environ Health Perspect (2008) 1.71
Domperidone and ventricular arrhythmia or sudden cardiac death: a population-based case-control study in the Netherlands. Drug Saf (2010) 1.66
Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years. J Allergy Clin Immunol (2005) 1.63
A nationwide study of three invasive treatments for trigeminal neuralgia. Pain (2011) 1.60
Incidence of mucocutaneous reactions in children treated with niflumic acid, other nonsteroidal antiinflammatory drugs, or nonopioid analgesics. Pediatrics (2005) 1.55
Marketing in the lay media and prescriptions of terbinafine in primary care: Dutch cohort study. BMJ (2004) 1.55
No increased risk of non-Hodgkin's lymphoma with steroids, estrogens and psychotropics (Netherlands). Cancer Causes Control (2003) 1.55
Nosocomial rotavirus infection in European countries: a review of the epidemiology, severity and economic burden of hospital-acquired rotavirus disease. Pediatr Infect Dis J (2006) 1.54
Swimming pool attendance and exhaled nitric oxide in children. J Allergy Clin Immunol (2006) 1.52
Effect of early antiretroviral therapy on the risk of AIDS/death in HIV-infected infants. AIDS (2009) 1.49
Inappropriate drug prescribing in older adults: the updated 2002 Beers criteria--a population-based cohort study. Br J Clin Pharmacol (2005) 1.44
Effects of nutritional rehabilitation on intestinal function and on CD4 cell number in children with HIV. J Pediatr Gastroenterol Nutr (2002) 1.43
Incidence of facial pain in the general population. Pain (2009) 1.42
Intussusception among young children in Europe. Pediatr Infect Dis J (2006) 1.42
The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns. Vaccine (2012) 1.41
Clinical manifestations and socio-economic impact of influenza among healthy children in the community. J Infect (2011) 1.40
Electronic healthcare databases for active drug safety surveillance: is there enough leverage? Pharmacoepidemiol Drug Saf (2012) 1.36
Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care. J Hypertens (2005) 1.31
Risk factors associated with adverse drug reactions following hospital admission: a prospective analysis of 907 patients in two German university hospitals. Drug Saf (2008) 1.29
Changing patterns of clinical events in perinatally HIV-1-infected children during the era of HAART. AIDS (2007) 1.28
Chronic disease prevalence from Italian administrative databases in the VALORE project: a validation through comparison of population estimates with general practice databases and national survey. BMC Public Health (2013) 1.27
Adverse drug reaction-related hospitalisations: a population-based cohort study. Pharmacoepidemiol Drug Saf (2008) 1.27
Impact of community-acquired paediatric rotavirus gastroenteritis on family life: data from the REVEAL study. BMC Fam Pract (2010) 1.24
Survey of adverse drug reactions on a pediatric ward: a strategy for early and detailed detection. Pediatrics (2002) 1.23
Risk factors associated with adverse drug reactions in hospitalised children: international multicentre study. Eur J Clin Pharmacol (2011) 1.22
COPD in the general population: prevalence, incidence and survival. Respir Med (2011) 1.22
Prevalence, incidence, and lifetime risk for the development of COPD in the elderly: the Rotterdam study. Chest (2009) 1.21
The safety and effectiveness of deferiprone in a large-scale, 3-year study in Italian patients. Br J Haematol (2002) 1.21
Determinants for the adoption of angiotensin II receptor blockers by general practitioners. Soc Sci Med (2006) 1.20
Sexual problems and help-seeking behaviour in adults in the United Kingdom and continental Europe. BJU Int (2008) 1.16
Burden of community-acquired and nosocomial rotavirus gastroenteritis in the pediatric population of Western Europe: a scoping review. BMC Infect Dis (2012) 1.16
The EU-ADR project: preliminary results and perspective. Stud Health Technol Inform (2009) 1.15
Exhaled breath condensate cysteinyl leukotrienes are increased in children with exercise-induced bronchoconstriction. J Allergy Clin Immunol (2005) 1.15
Five-year follow-up of children with perinatal HIV-1 infection receiving early highly active antiretroviral therapy. BMC Infect Dis (2009) 1.14
Role of p-glycoprotein inhibition for drug interactions: evidence from in vitro and pharmacoepidemiological studies. Clin Pharmacokinet (2007) 1.14
Immune reconstitution in HIV-1-infected children on antiretroviral therapy: role of thymic output and viral fitness. AIDS (2002) 1.14
Distribution of rotavirus genotypes in Europe, 2004-2005: the REVEAL Study. J Infect Dis (2007) 1.13
Pharmacokinetics of nelfinavir and its active metabolite, hydroxy-tert-butylamide, in infants perinatally infected with human immunodeficiency virus type 1. Pediatr Infect Dis J (2003) 1.13
Early therapy in HIV-1-infected children: effect on HIV-1 dynamics and HIV-1-specific immune response. Antivir Ther (2008) 1.13
Pro: swimming in chlorinated pools and risk of asthma: we can now carry on sending our children to swimming pools! Am J Respir Crit Care Med (2011) 1.12
Current understandings on complex regional pain syndrome. Pain Pract (2008) 1.12
Identification of adverse drug reactions in geriatric inpatients using a computerised drug database. Drugs Aging (2003) 1.12
Epidemiology and potential associated risk factors of drug-related problems in hospitalised children in the United Kingdom and Saudi Arabia. Eur J Clin Pharmacol (2012) 1.11
All-cause mortality associated with atypical and typical antipsychotics in demented outpatients. Pharmacoepidemiol Drug Saf (2007) 1.11
Genetic polymorphisms and heart failure. Genet Med (2004) 1.11
The Safety of Drug Therapy in Children. Dtsch Arztebl Int (2015) 1.11
Nonsteroidal anti-inflammatory drugs and heart failure. Drugs (2003) 1.11
The term "asthma" should be avoided in describing the chronic pulmonary disease of prematurity. Eur Respir J (2013) 1.10
Economics of rotavirus gastroenteritis and vaccination in Europe: what makes sense? Pediatr Infect Dis J (2006) 1.10
Inappropriate initial treatment of secondary intra-abdominal infections leads to increased risk of clinical failure and costs. Br J Clin Pharmacol (2005) 1.10
Tiotropium and the risk of death in COPD. N Engl J Med (2014) 1.09